GlassScriptPhysician profile
Adam Nowland
NPI 1932594330
$1,598.29
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $1,156.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $892.00 | 2020 | |
| Crossroads Extremity Systems, LLC | $205.18 | 2019-2020 | |
| Integra Lifesciences Corporation | $164.22 | 2019-2020 | |
| Stryker Corporation | $140.53 | 2019-2020 | |
| Horizon Therapeutics Plc | $59.18 | 2019 | |
| Smith+Nephew, INC. | $42.13 | 2019 | |
| Melinta Therapeutics, LLC | $41.94 | 2019 | |
| Sebela Pharmaceuticals INC. | $19.64 | 2020 | |
| Omeros Corporation | $18.41 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.06 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Nowland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.